Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.
3-year invasive disease-free survival with chemotherapy de-escalation using an (18)F-FDG-PET-based, pathological complete response-adapted strategy in HER2positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
Recommended Dosages The maintenance dosage for subcutaneous semaglutide is up to 2.4mg once weekly , which should be achieved gradually following a dose escalation schedule [13]
Hexokinase 2 promotes cell proliferation and tumor formation through the wnt/-catenin pathway-mediated cyclin D1/c-myc upregulation in epithelial ovarian cancer
US$ 29.15
US$ 22.67
US$ 23.24
US$ 23.94
US$ 27.00
US$ 28.04
